Evidence map›Paper›PMID 25638335›Full record

ReviewCurrent topics in behavioral neurosciences2015

Nicotine withdrawal.

Ian McLaughlin, John A Dani, Mariella De Biasi

Abstract readReview
In one paragraph

Review in Current topics in behavioral neurosciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 6 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 6 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Role of microRNAs in the pathophysiology of addiction.Wiley interdisciplinary reviews. RNA · 2021
    Pooled it
  6. Delay discounting of different outcomes: Review and theory.Journal of the experimental analysis of behavior · 2020
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ian McLaughlinDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
John A Dani
Mariella De Biasi
University of Pennsylvania · US

Funding

Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
STRUCTURE/FUNCTION OF EXCITATORY SYNAPTIC CHANNELSR01NS021229 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1987 to 2021
$5.3M
T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
CELLULAR MECHANISMS OF NICOTINE ADDICTIONR01DA009411 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1997 to 2018
$5.0M
Alpha 5 nAChR is a Risk Factor within the Dopamine System for Nicotine AddictionR01DA036572 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 2014 to 2018
$2.3M
Regulation of Proteasomal Function by NicotineR21DA024385 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI DE BIASI, MARIELLA · 2008 to 2009
$307k
NCI NIH HHS U19 CA148127NCI NIH HHS U19CA148127NIDA NIH HHS DA009411NIDA NIH HHS DA024385NIDA NIH HHS DA036572NIDA NIH HHS R01 DA009411NIDA NIH HHS R01 DA036572NIDA NIH HHS R21 DA024385NIDA NIH HHS T32 DA028874NINDS NIH HHS R01 NS021229
6 · The paper itself

Abstract

An aversive abstinence syndrome manifests 4-24 h following cessation of chronic use of nicotine-containing products. Symptoms peak on approximately the 3rd day and taper off over the course of the following 3-4 weeks. While the severity of withdrawal symptoms is largely determined by how nicotine is consumed, certain short nucleotide polymorphisms (SNPs) have been shown to predispose individuals to consume larger amounts of nicotine more frequently--as well as to more severe symptoms of withdrawal when trying to quit. Additionally, rodent behavioral models and transgenic mouse models have revealed that specific nicotinic acetylcholine receptor (nAChR) subunits, cellular components, and neuronal circuits are critical to the expression of withdrawal symptoms. Consequently, by continuing to map neuronal circuits and nAChR subpopulations that underlie the nicotine withdrawal syndrome--and by continuing to enumerate genes that predispose carriers to nicotine addiction and exacerbated withdrawal symptoms--it will be possible to pursue personalized therapeutics that more effectively treat nicotine addiction.

Indexed as

BrainSubstance Withdrawal SyndromeAnimalsHumansNicotineReceptors, NicotinicNicotineReceptors, Nicotinic

Identifiers

PMID25638335
PMCPMC4542051
OpenAlexW4211219695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.